
|Articles|August 1, 2004
Combined therapy provides better control of HIV
The human immunodeficiency virus (HIV) attacks the immune system, particularly white blood cells known as CD4 T-cells. As a result, the immune system becomes less able to fight off infection and disease. The final stage of HIV infection is acquired immunodeficiency syndrome (AIDS), but some people live with HIV for years or even decades before the disease progresses to AIDS.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Patients may not see savings from new Medicare drug programs
2
Sanofi acquires Dynavax for $2.2 billion to bolster vaccine portfolio
3
Why Timing, Access and Interpretation Matter in Oncology Biomarker Testing
4
A jump in shingles after first Shingrix dose but the risk is transient, study finds
5




















































